Fellow of The Academy of Medical Sciences, United Kingdom
His scientific interests lie mostly in Immunology, Inflammation, Endothelial stem cell, Internal medicine and Molecular biology. His Immunology research incorporates elements of Uric acid and In vivo. The various areas that Dorian O. Haskard examines in his Inflammation study include Tumor necrosis factor alpha, Gout, Disease, Cell biology and Macrophage.
His Endothelial stem cell study integrates concerns from other disciplines, such as Proinflammatory cytokine, Interleukin and Umbilical vein. The Internal medicine study combines topics in areas such as Endocrinology and E-selectin. His work deals with themes such as T cell, Antigen, Liver X receptor, Receptor and Lymphocyte, which intersect with Molecular biology.
The scientist’s investigation covers issues in Immunology, Cell biology, Internal medicine, Inflammation and Molecular biology. His research integrates issues of Cell adhesion, Macrophage and In vivo in his study of Immunology. His Cell biology research includes elements of Endothelial stem cell, Decay-accelerating factor, Angiogenesis and Transcription factor.
In Endothelial stem cell, Dorian O. Haskard works on issues like Endothelium, which are connected to Pharmacology. His Internal medicine study which covers Complement system that intersects with LDL receptor. He focuses mostly in the field of Inflammation, narrowing it down to matters related to Tumor necrosis factor alpha and, in some cases, Cytokine.
His main research concerns Internal medicine, Immunology, Cell biology, Pathology and AMPK. Dorian O. Haskard interconnects Gastroenterology and Diabetes mellitus, Endocrinology in the investigation of issues within Internal medicine. Dorian O. Haskard combines subjects such as Macrophage and CD163 with his study of Immunology.
His work carried out in the field of Cell biology brings together such families of science as Apoptosis and ATF1. His studies deal with areas such as Inflammation and Molecular biology as well as Tumor necrosis factor alpha. His research in Endothelium tackles topics such as Signal transduction which are related to areas like Endothelial stem cell.
His primary areas of investigation include Pathology, Immunology, Internal medicine, Pharmacology and Tumor necrosis factor alpha. His Pathology study incorporates themes from Molecular imaging, In vivo, Apoptosis and Cell biology. His Immunology study combines topics in areas such as Peripheral blood mononuclear cell, Oxidized low density lipoprotein and CD163.
His Internal medicine research includes themes of Endocrinology, Immunoglobulin M and Bioinformatics. His research in Pharmacology intersects with topics in Inflammation, AMPK, CREB and Kinase. His Inflammation study typically links adjacent topics like Cardiopulmonary bypass.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Expression of intercellular adhesion molecule-1 in atherosclerotic plaques.
R N Poston;D O Haskard;J R Coucher;N P Gall.
American Journal of Pathology (1992)
Association of Maternal Endothelial Dysfunction With Preeclampsia
John C. Chambers;Luca Fusi;Iqbal S. Malik;Dorian O. Haskard.
Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery.
P. Philippidis;J.C. Mason;B.J. Evans;I. Nadra.
Circulation Research (2004)
Sudden sensorineural hearing loss
Benjamin E Schreiber;Charlotte Agrup;Dorian O Haskard;Linda M Luxon.
The Lancet (2010)
Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.
M. H. Thornhill;S. M. Wellicome;D. L. Mahiouz;J. S. S. Lanchbury.
Journal of Immunology (1991)
Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis
Iqbal Malik;John Danesh;Peter Whincup;Vinay Bhatia.
The Lancet (2001)
Endothelial von Willebrand factor regulates angiogenesis
Richard D. Starke;Francesco Ferraro;Koralia E. Paschalaki;Nicola H. Dryden.
Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways : A vicious cycle of inflammation and arterial calcification?
Imad Nadra;Justin C. Mason;Pandelis Philippidis;Oliver Florey.
Circulation Research (2005)
Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers.
D E Cavender;D O Haskard;B Joseph;M Ziff.
Journal of Immunology (1986)
A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide.
S M Wellicome;M H Thornhill;C Pitzalis;D S Thomas.
Journal of Immunology (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: